Search Results 61 – 80 of 108
Table 2. Treatment of HIV-Associated Opportunistic Infections (Includes Recommendations for Acute Treatment and Secondary Prophylaxis/Chronic Suppressive/Maintenance Therapy)
Appendix A. Key to Acronyms
Appendix B. Important Guideline Considerations
Appendix C. Panel Members
Table 3. Indications for Discontinuing and Restarting Primary and Secondary Prophylaxis (or Chronic Maintenance Therapy) for Selected Opportunistic Infections in Adults and Adolescents with HIV
Appendix D. Financial Disclosures
Table 4. Significant Pharmacokinetic Interactions Between Drugs Used to Treat or Prevent Opportunistic Infections
Appendix E. Archived Sections
Table 5. Serious and/or Common Adverse Reactions Associated with Systemically Administered Drugs Used to Treat or Prevent Opportunistic Infections
Overview
Table 6. Dosing Recommendations for Drugs Used to Treat or Prevent Opportunistic Infections That Require Dosage Adjustment in Patients with Renal Insufficiency
Human Herpesvirus 8
Influenza
Progressive Multifocal Leukoencephalopathy
Figures
Tables
Appendix A: List of Abbreviations
Figure 1. Recommended Immunization Schedule for Children with HIV Infection Aged 0 through 18 Years; United States, 2019
Table 1. Primary Prophylaxis
Table 2. Secondary Prophylaxis